trending Market Intelligence /marketintelligence/en/news-insights/trending/rkleqwtygfy8hpti56dlrw2 content esgSubNav
In This List

Court sides with Pacific Biosciences in patent eligibility ruling

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Court sides with Pacific Biosciences in patent eligibility ruling

A U.S. court denied Oxford Nanopore Technologies Ltd's motion to dismiss a lawsuit filed by Pacific Biosciences of California Inc. for alleged patent infringement of its genome sequencing technology.

Judge Leonard Stark of the U.S. District Court for the District of Delaware denied the U.K.-based Oxford Nanopore's motion, which alleged that Pacific Biosciences' patent claims contain ineligible subject matter.

In November 2017, the U.S. District Court for the District of Delaware denied Oxford Nanopore's motion to dismiss another companion patent infringement case brought by Pacific Biosciences.

In a separate litigation in February, the U.S. International Trade Commission ruled that Oxford Nanopore did not infringe on Menlo Park, Calif.-based Pacific Biosciences' patents for certain molecule analysis devices.